Lori Cory, MD, MSCE

Gynecologic Oncology
Accepting new patients
Sees patients age 12 and up
LG Health Physicians Gynecologic Oncology
Make an appointmentCall 717-544-9400
Headshot of Lori Cory, MD, MSCE
Penn Medicine Provider

About me

  • Managing Physician for ABBCI's Gynecologic Oncology practice
  • Adjunct Assistant Professor of Obstetrics and Gynecology

My education and training

  • Medical School: University of Pennsylvania School of Medicine
  • Residency: University of Pennsylvania Health System
  • Fellowship: University of Pennsylvania Health System

Reviews

Average Rating

104 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
April 2026
with dr cory there are no dumb or embarrassing questions. she makes me feel very comfortable.
Anonymous
April 2026
excellent visit each time.
Anonymous
April 2026
i travel quite a distance to see dr. cory as she is a kind, considerate and amazing doctor. she was the first cancer doctor i met and from day one i trusted her completely.
Anonymous
April 2026
she is very good at what she does

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Cory is a Penn Medicine Lancaster General Health physician.

Qualifications and experience

Treatments and Conditions

Research

Publications

Nugent ST, Raj LK, Latif NA, Cory L, Tanyi JL, Kovach SJ 3rd, Fischer JP, Fosnot J, Lin IC, Etzkorn JR, Shin TM, Giordano CN, Higgins HW 2nd, Walker JL, Miller CJ A retrospective case series of Mohs micrographic surgery and interdisciplinary management of female genital skin cancers: Local recurrence rates and patient-reported outcomes , J Am Acad Dermatol: 2023,S0190-9622(23)00362-6. doi: 10.1016/j.jaad.2023.02.050

Nasioudis D, Latif NA, Ko EM, Cory L, Kim SH, Simpkins F, Morgan MA, Giuntoli RL 2nd Facility level variation in the utilization of neoadjuvant chemotherapy is associated with higher surgical morbidity for patients with advanced stage epithelial ovarian carcinoma. , Gynecol Oncol: 2023,169:41-46. doi: 10.1016/j.ygyno.2022.10.025

Saris DH, Tubridy E, Gleason E, Breensinger C, Cory L, Latif N, Giuntoli R, Kim SH, Ko EM Access to Gynecologic Oncologist Specialist Care for Endometrial Cancer Patients in the United States. , SGO Winter: 2023

Nasioudis D, Taunk NK, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA Addition of External Beam Radiation Therapy to Adjuvant Chemotherapy for Patients With Stage IIIC Uterine Endometrioid Carcinoma: Utilization and Outcomes. , Am J Clin Oncol: 2022,45(9):373-378. doi: 10.1097/COC.0000000000000927

Nasioudis D, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Ko EM Outcomes of sentinel lymph node mapping for patients with endometrial carcinoma and cervical or extrauterine involvemenet (T2,T3A, or T3B) , International Gynecologic Cancer Society Meeting, New York: 2022

Nasioudis D, Latif NA, Haggerty AF, Cory L, Giuntoli II RL, Kim SH, Morgan MA, Simpkins F, Ko EM Molecular landscape of EBBR2/HER2 gene amplification among patients with endometrial carcinoma” , Featured Poster International Gynecologic Cancer Society Meeting, New York : 2022

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Morgan MA, Latif NA Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database , Gynecol Oncol: 2022,166(2):263-268. doi: 10.1016/j.ygyno.2022.05.015

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Morgan MA, Latif NA Delay in adjuvant chemotherapy administration for patients with FIGO stage I epithelial ovarian carcinoma is associated with worse survival; an analysis of the National Cancer Database. , Gynecol Oncol, 166(2):263-268: 2022

Nasioudis D, Rush M, Taunk NK, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA Oncologic outcomes of surgical para-aortic lymph node staging in patients with advanced cervical carcinoma undergoing chemoradiation. , Int J Gynecol Cancer: 2022,32(7):823-827. doi: 10.1136/ijgc-2022-003394

Nasioudis D, Mastroyannis SA, Ko EM, Haggerty AF, Cory L, Giuntoli RL 2nd, Kim SH, Latif NA Safety of ovarian preservation for premenopausal patients with FIGO stage I grade 2 and 3 endometrioid endometrial adenocarcinoma , Int J Gynecol Cancer: 2022,ijgc-2022-003450. doi: 10.1136/ijgc-2022-003450